Anthracyclines, commonly used for various cancers, are associated with cardiomyopathy and primary cancer treatment-induced arrhythmias.
Supports arrhythmia surveillance in anthracycline recipients; leaves open prospective trials to guide prevention.
Anthracyclines are commonly used in the treatment of breast cancer, acute leukemia, lymphomas, and childhood solid tumors. Cardiomyopathy is the most common cardiac toxicity of anthracyclines, but they can often cause primary CTIA,
No takes yet. Share an insight, caveat, or question.
Buza et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: